Differences in the prevalence of obesity, blood samples (i.e. serum vs. plasma) and laboratory tests (i.e. radioimmunoassay vs enzyme immunoassay) can significantly affect measured adiponectin concentrations, making comparisons challenging. This evidence concerns the gene ADIPOQ and obesity disorder.